NAUT - Nautilus Biotechnology reports Q3 results November, 02 2021 06:03 AM Nautilus Biotechnology Inc. Nautilus Biotechnology (NASDAQ:NAUT): Q3 GAAP EPS of -$0.12. Cash, cash equivalents, and investments were $374.0M as of September 30, 2021. For further details see: Nautilus Biotechnology reports Q3 results